Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $886.35 million. The enterprise value is $499.68 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 52.81 million shares outstanding. The number of shares has increased by 16.28% in one year.
| Current Share Class | 52.81M |
| Shares Outstanding | 52.81M |
| Shares Change (YoY) | +16.28% |
| Shares Change (QoQ) | +12.33% |
| Owned by Insiders (%) | 4.32% |
| Owned by Institutions (%) | 32.23% |
| Float | 10.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.46, with a Debt / Equity ratio of 0.02.
| Current Ratio | 36.46 |
| Quick Ratio | 36.19 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.50% and return on invested capital (ROIC) is -19.03%.
| Return on Equity (ROE) | -26.50% |
| Return on Assets (ROA) | -18.57% |
| Return on Capital (ROIC) | -19.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.66M |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.16% in the last 52 weeks. The beta is 1.08, so TYRA's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +23.16% |
| 50-Day Moving Average | 22.16 |
| 200-Day Moving Average | 19.13 |
| Relative Strength Index (RSI) | 32.93 |
| Average Volume (20 Days) | 570,963 |
Short Selling Information
The latest short interest is 2.20 million, so 4.17% of the outstanding shares have been sold short.
| Short Interest | 2.20M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 21.42% |
| Short Ratio (days to cover) | 11.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -95.45M |
| Pretax Income | -80.88M |
| Net Income | -81.44M |
| EBITDA | -95.02M |
| EBIT | -95.45M |
| Earnings Per Share (EPS) | -$1.66 |
Full Income StatementBalance Sheet
The company has $373.80 million in cash and $6.40 million in debt, giving a net cash position of $367.40 million or $6.96 per share.
| Cash & Cash Equivalents | 373.80M |
| Total Debt | 6.40M |
| Net Cash | 367.40M |
| Net Cash Per Share | $6.96 |
| Equity (Book Value) | 376.04M |
| Book Value Per Share | 7.13 |
| Working Capital | 368.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$62.96 million and capital expenditures -$1.29 million, giving a free cash flow of -$64.26 million.
| Operating Cash Flow | -62.96M |
| Capital Expenditures | -1.29M |
| Free Cash Flow | -64.26M |
| FCF Per Share | -$1.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |